Skip to Main Content

Paper Details

Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y<sub>12</sub> Inhibitor Therapy: A Meta-Analysis.
JACC Cardiovasc Interv
84
2021
CAD, CYP2C19, CYP2C19 Genotype, CYP2C19 genotype, P2Y12, Ticagrelor, acute coronary syndromes, cardiovascular death, clopidogrel, coronary artery disease, ischemia, myocardial infarction, patients, prasugrel, stent thrombosis, stroke, ticagrelor
Author NameAffiliation
Naveen L PereiraMayo Clinic
Malcolm R BellMayo Clinic
Yves Rosenbergand Blood Institute, National Institutes of Health
Kent R BaileyMayo Clinic
Mohammad Hassan MuradMayo Clinic
Mohammad Hassan MuradMayo Clinic
  • 1 - 6

Datasets

Release 1.2